Document is current
Any future updates will be listed below
-
Authors
Kustatscher, Georg https://orcid.org/0000-0001-8955-0866
Collins, Tom
Gingras, Anne-Claude https://orcid.org/0000-0002-6090-4437
Guo, Tiannan https://orcid.org/0000-0003-3869-7651
Hermjakob, Henning https://orcid.org/0000-0001-8479-0262
Ideker, Trey
Lilley, Kathryn S. https://orcid.org/0000-0003-0594-6543
Lundberg, Emma https://orcid.org/0000-0001-7034-0850
Marcotte, Edward M. https://orcid.org/0000-0001-8808-180X
Ralser, Markus
Rappsilber, Juri https://orcid.org/0000-0001-5999-1310
-
Funding
Funding for this research was provided by:
Wellcome Trust (203149)
Deutsche Forschungsgemeinschaft (390540038)
- License Information
-
More Information
Article History
First Online: 9 May 2022
Competing interests
: T.G. is a shareholder of Westlake Omics Inc. T.I. is a co-founder of Data4Cure, is on its Scientific Advisory Board and has an equity interest. T.I. is on the Scientific Advisory Board of Ideaya BioSciences and has an equity interest. E.L. is advisor for Pixelgen Technologies and Moleculent. E.M.M. is a co-founder, shareholder and scientific board member of Erisyon, Inc. G.K., T.C., A.-C.G., H.H., K.L., M.R. and J.R. declare no competing interests.
